Antiviral therapy against Neuroinvasive West Nile virus: Metformin, the widely used drug in the treatment of TIIDM, increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 22/July/2017, 12.08 am
https://genomediscovery.org/wp-content/uploads/2017/07/Metformin-inhibits-RIPK3-expression-and-promotes-clearance-of-neuroinvasive-West-Nile-virus-WNV.jpg
960
720
Dr Boomi's Genom-2-Discovery Center
https://genomediscovery.org/wp-content/uploads/2017/07/Metformin-inhibits-RIPK3-expression-and-promotes-clearance-of-neuroinvasive-West-Nile-virus-WNV.jpg
Introduction: What they say A study from the Department of Immunology, University of Washington, Seattle, WA 98109, USA; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109,…
read more

